Lava Medtech Acquisition OverviewLatest ebit for LVAC: $-870K, above the sector sector average of $-63M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022
As of the most recent data (December 2022), LVAC shows a EBIT of $-870K. That is above the sector sector average of $-63M. Scroll down for historical charts and peer comparison views.
The its sector sector average EBIT is about $-63M. Lava Medtech Acquisition is at $-870K, which is higher that average. That is roughly 98.6% above the sector mean. Use the comparison chart on this page to see how LVAC stacks up against individual peers as well.
Tracking LVAC's ebit over time shows whether Lava Medtech Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $-870K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Lava Medtech Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-870K) with ownership activity and broader fundamentals.
